Overcoming COVID-19 Vaccine Hesitancy: Insights from an Online Population-Based Survey in the United States

Author:

Badr HodaORCID,Zhang Xiaotao,Oluyomi Abiodun,Woodard LeChauncy D.,Adepoju Omolola E.,Raza Syed Ahsan,Amos Christopher I.ORCID

Abstract

This study sought to identify individual-level determinants of COVID-19 vaccine hesitancy based on the Health Belief Model (HBM) and Theory of Planned Behavior (TPB). An online population-based survey was distributed in English and Spanish. Data were derived from 1208 U.S. adults (52% female; 38.7% minorities), 43.5% of whom reported vaccine hesitancy. Multivariable analysis revealed that unemployed individuals were more likely (OR = 1.78, 95% CI: 1.16–2.73, p = 0.009) and married (OR = 0.57, 95% CI: 0.39–0.81, p = 0.002) and higher income individuals (OR = 0.52, 95% CI 0.32–0.84, p = 0.008) were less likely to be hesitant. Individuals with greater perceived susceptibility to COVID-19 (OR = 0.82, 95% CI: 0.71–0.94, p = 0.006), who perceived vaccination as being convenient (OR = 0.86, 95% CI: 0.74–1.00, p = 0.047), and who afforded greater importance to cues to action from government (OR = 0.84, 95% CI: 0.74–0.95, p = 0.005), public health (OR = 0.70, 95% CI: 0.59–0.82, p < 0.001), and healthcare experts (OR = 0.59, 95% CI: 0.50–0.69, p < 0.001) were also less likely to be hesitant. Findings suggest that HBM and TPB constructs may be useful in informing strategies to improve COVID-19 vaccine uptake. Specifically, framing appeals based on perceptions of COVID-19 susceptibility, making vaccination convenient, and rebuilding trust through unified cues to action may help to overcome vaccine hesitancy.

Funder

National Heart Lung and Blood Institute

Cancer Prevention and Research Institute of Texas

National Cancer Institute

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference45 articles.

1. How Efficacious Must a COVID-19 Coronavirus Vaccine be to Prevent or Stop an Epidemic by Itself;Bartsch;medRxiv,2020

2. A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2

3. Fauci Says Herd Immunity Could Require Nearly 90% to get Coronavirus Vaccinehttps://www.yahoo.com/now/fauci-says-herd-immunity-could-174247972.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAMgUX9oNTtQhs4fByoB4fwgDX9DOBDKGbNHN4yEeL29XnplZomddai-ttS5C7kX7ZuDXkpDnCuBGLQiZIWehg-zj-aVmNTw9FaUzkpWanp6PBnFIsP8uL-Lt3LSQKR47ZCcC6QYXYY2aReyd8Jl_3hzd20vQsZp0Wj1KYlMznLQ5

4. COVID vaccines and safety: what the research says

5. Tracking Coronavirus Vaccinations Around the Worldhttps://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3